Will Guangdong drug bidding rules change? Or March 1

Source: sebilan 2014-11-6, as a major province of drug sales, Guangdong drug exchange has always been the focus of the industry, among which the policy of monthly bidding, only low price is to take has been controversial Recently, cypress blue learned from sources that the trading rules of the drug exchange may change The discussion draft of the transaction rules shows that the changes of the transaction rules are mainly in the following aspects: 1 The factory price record is no longer used as the registration condition 2 The bidding period of drug trade is changed from once a month to once in March 3 The price department will no longer calculate the entry price, but will be specifically responsible by the trading organization 4 Low price medicine: the manufacturer makes its own price, and the hospital chooses the medicine with high quality and low price 5 The price quoted by multiple manufacturers shall not be higher than the average market price of the same group 6 Small volume injection water needle and water needle are combined into groups 7 No matter whether there is market price or not, all the basic medicine or non basic medicine medical insurance varieties that are exclusive at the time of registration will be negotiated The products that are exclusive after the volume is reported will still be traded by bidding 8 Non marketable product: for the exclusive product, select the closest dosage form from other manufacturers, and calculate the market price based on the specification difference ratio; for multiple products, the average market price of the same group is the market price 9 For the drugs that are clinically necessary for first aid and severe treatment but fail to win the bid, the hospitals above the county level can record and purchase them On May 17, 2013, Guangdong pharmaceutical procurement platform released a draft for comments, which plans to reform the current centralized bidding procurement mode of drugs, and turn to online trading on the third-party drug electronic trading platform At the same time, it is clear that online purchase will be adopted for the hospital to purchase drugs, only the varieties and purchase quantities will be reported, and the manufacturer will complete the transaction by bidding Soon, five industry associations, including the China Pharmaceutical Enterprise Management Association, jointly wrote to the Legal Affairs Office of the State Council, the national development and Reform Commission and other relevant departments that the trading rules of Guangdong Pharmaceutical exchange are the new form of "only taking low price", and put forward a large number of modification opinions, hoping that relevant departments would pay attention to it and make "fundamental modification" Sabilan interviewed a senior person in the pharmaceutical industry He said that the rules of Guangdong drug exchange tend to be reasonable in general, but it remains to be seen whether it can correct the previous low price According to the industry insiders, the previous trading rules stipulated that drugs should be priced once a month, completely divorced from the actual situation of drug production operation Too short purchase period brings great difficulties to the organization and production of enterprises, and pharmaceutical factories, commercial companies and medical institutions should frequently carry out inventory and settlement of new and old drugs, which affects the normal business order, and also brings adverse effects on the safety and sustainability of clinical medication in hospitals The previous determination of market entry price is mainly determined by the price department according to the average bid price of some provinces and cities, the purchase price of Guangdong Province and other data Now, the transaction agency is responsible for the determination In the future, the hospital and pharmaceutical enterprises will negotiate the price, but it is not clear what kind of rules the two sides will negotiate according to.